Navigation Links
New Latent TB Drug Saves Lives, Money
Date:5/20/2008

Rifampin improved compliance, reduced side effects, saved $10,000 per patient

TUESDAY, May 20 (HealthDay News) -- Using the drug Rifampin to treat people with latent tuberculosis saves time, money and lives, new research shows.

"We found that using a therapy of four months of Rifampin instead of the current nine months of Isoniazid costs significantly less for the health-care system," lead analyst Anne Aspler, of the respiratory epidemiology and clinical research unit at McGill University's Montreal Chest Clinic, said in a prepared statement.

"Overall, Rifampin costs about $484 less per patient treated, which, if we assume that four months of Rifampin has a least equal efficacy to nine months of Isoniazid, represents an added savings to the health system of more than $10,000 per patient prevented from developing [full-blown] TB disease. And because of improvements in compliance, we are actually preventing more cases. This treatment can save money as well as lives," Aspler said.

The study was expected to be presented Tuesday at the American Thoracic Society's International Conference, in Toronto.

Currently, about 2 billion people worldwide are believed to have latent, or dormant, TB. Of those, 8 million to 9 million will develop TB each year, and 1.6 million of them will die.

TB is most prevalent in developing countries, where Rifampin is offered at a subsidized cost through the Global Drug Facility of the World Health Organization. Not only is Rifampin less expensive, it has better patient compliance than Isoniazid due to the shorter treatment time, according to Aspler.

"While Isoniazid therapy is 90 percent effective for those who complete it, in reality, fewer than 50 percent do," Aspler said. This low compliance rate can have serious health consequences for patients who fail to complete treatment and for those they later infect.

Previous research and experience suggests that a four-month treatment program improves patient compliance by 20 percent to 25 percent, and reduces the risk of serious side effects such as liver damage.

"The next step in research is a major phase III clinical trial of efficacy -- ideally in HIV-infected and non-infected patients and in low-income settings where tuberculosis is the leading cause of death in people living with HIV," Aspler said.

More information

The National Institute of Allergy and Infectious Diseases has more about TB.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, May 20, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New chemical can kill latent tuberculosis bacteria
2. Rifampin: Latent TB treatment saves time money and lives
3. Surgery for severe obesity saves lives
4. Early Breast Cancer Detection Saves Lives
5. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
6. iPlan(R) Automatic Segmentation Saves 25 Minutes of Treatment Planning Time for Each Prostate Cancer Patient at the University of Nebraska Medical Center
7. Fetal Surgery Saves Baby After Early Water Break
8. Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions
9. Wal-Mart Saves Customers More Than $1 Billion On Prescription Drugs
10. Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act
11. American College of Medical Genetics Commends the Signing of the Newborn Screening Saves Lives Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology: